Triumvira to Present Corporate Update at the Bloom Burton & Co. Healthcare Investor Conference HAMILTON, ON and HACKENSACK, NJ--(Marketwired - April 25, 2017) - Triumvira Immunologics Inc. today announced that its President and Chief Executive Officer Tony Fiorino, MD, PhD, will present a...

Triumvira to Present Corporate Update at the 24th Annual Future Leaders in the Biotech Industry HAMILTON, ON and HACKENSACK, NJ--(Marketwired - April 03, 2017) - Triumvira Immunologics Inc. today announced that its President and Chief Executive Officer Tony Fiorino, MD, PhD, will present a...

New CD19 and BCMA Data to be Presented at the Society for Immunotherapy of Cancer Annual Meeting HAMILTON, ON and HACKENSACK, NJ--(Marketwired - November 10, 2016) - Triumvira Immunologics today announced that new data on the TAC platform will be presented Friday, November 11 at the 31st Annual...

Solid Tumor Preclinical Data for HER2 TAC-T Cells Presented at the Summit for Cancer Immunotherapy HAMILTON, ON and HACKENSACK, NJ--(Marketwired - June 28, 2016) - Triumvira Immunologics Inc. today announced that its Head of Platform Development, Christopher Helsen, PhD, presented a talk entitled...

Triumvira to Present Corporate Update at the Bloom Burton & Co. Healthcare Investor Conference HAMILTON, ON and HACKENSACK, NJ --(Marketwired - April 25, 2016) - Triumvira Immunologics Inc. today announced that its President and Chief Executive Officer Tony Fiorino, MD, PhD, will present a...